Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Corvol

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Cancer Research|March 26, 2009
Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic miceFrançois Vincent, Philippe Bonnin, Maud Clemessy, et al.
The American Journal of Pathology|April 23, 2003
Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinomaSébastien Le Jan, Céline Amy, Aurélie Cazes, et al.
Hypertension (Dallas, Tex. : 1979)|February 8, 2003
Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin IIJustin M Cole, Nata Khokhlova, Roy L Sutliff, et al.
Cancer Research|September 23, 2003
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomasAnne-Paule Gimenez-Roqueplo, Judith Favier, Pierre Rustin, et al.
Rheumatology (Oxford, England)|April 2, 2011
Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosisJérôme Avouac, Maud Clemessy, Jörg H Distler, et al.
Hypertension (Dallas, Tex. : 1979)|October 8, 2003
Genetic determinants of nonmodulating hypertensionNatapong Kosachunhanun, Steven C Hunt, Paul N Hopkins, et al.
The Journal of Biological Chemistry|February 6, 2004
Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in miceSebastien Fuchs, Hong D Xiao, Justin M Cole, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2006
Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasivenessAriane Galaup, Aurelie Cazes, Sebastien Le Jan, et al.
Plos One|December 17, 2008
Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient miceNicolas Bréchot, Elisa Gomez, Marine Bignon, et al.
The Journal of Clinical Investigation|July 4, 2007
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in miceSandrine Billet, Sabine Bardin, Sonia Verp, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Cancer Research|March 26, 2009
Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic miceFrançois Vincent, Philippe Bonnin, Maud Clemessy, et al.
The American Journal of Pathology|April 23, 2003
Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinomaSébastien Le Jan, Céline Amy, Aurélie Cazes, et al.
Hypertension (Dallas, Tex. : 1979)|February 8, 2003
Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin IIJustin M Cole, Nata Khokhlova, Roy L Sutliff, et al.
Cancer Research|September 23, 2003
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomasAnne-Paule Gimenez-Roqueplo, Judith Favier, Pierre Rustin, et al.
Rheumatology (Oxford, England)|April 2, 2011
Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosisJérôme Avouac, Maud Clemessy, Jörg H Distler, et al.
Hypertension (Dallas, Tex. : 1979)|October 8, 2003
Genetic determinants of nonmodulating hypertensionNatapong Kosachunhanun, Steven C Hunt, Paul N Hopkins, et al.
The Journal of Biological Chemistry|February 6, 2004
Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in miceSebastien Fuchs, Hong D Xiao, Justin M Cole, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2006
Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasivenessAriane Galaup, Aurelie Cazes, Sebastien Le Jan, et al.
Plos One|December 17, 2008
Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient miceNicolas Bréchot, Elisa Gomez, Marine Bignon, et al.
The Journal of Clinical Investigation|July 4, 2007
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in miceSandrine Billet, Sabine Bardin, Sonia Verp, et al.
Pageof 8